Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.. All

(1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for

HBV M protein production did not lead to formation of intracellular filamentous or spherical subviral envelope particles, although the pSFV1-MHBs adw construct also

Cross-neutralizing properties of antibodies induced by immunization with chimeric S+E1-S, S+E2-S or S+E1-S+E2-S particles in the presence of AddaVax ® adjuvant against

While this case report demonstrates that HBV/HCV co-infection can be satisfactorily treated in our setting, the high prevalence of both viral infections in Cameroon,

The GT Plus assay results in these samples were as follows (Table 4): (i) the genotype 1 subtype was resolved in seven specimens and results were confirmed either by the

Among the HCV-Ab positive samples, 15 patients had documented chronic HCV infection and presented a detectable HCV RNA and 4 patients had documented acute

direct sequence analysis of a portion of the nonstructural (NS) 5B-coding gene followed by phylogenetic analysis. The ability of the following commercial assays to correctly